Cell line IDG-SW3 replicates osteoblast-to-late-osteocyte differentiation in vitro and accelerates bone formation in vivo

Journal of Bone and Mineral Research

Volumn 26, Issue 11, 2011, Pages 2634-2646

  Woo, Stacey M ^a   Rosser, Jennifer ^a   Dusevich, Vladimir ^a   Kalajzic, Ivo ^b   Bonewald, Lynda F ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

FGF 23; IMMORTOMOUSE; OSTEOCYTE; SCLEROSTIN; SOST

Indexed keywords

ALKALINE PHOSPHATASE; CALCITRIOL; DENTIN MATRIX PROTEIN 1; FIBROBLAST GROWTH FACTOR 23; GAMMA INTERFERON; MATRIX EXTRACELLULAR PHOSPHOGLYCOPROTEIN; PARATHYROID HORMONE; PHOSPHATE REGULATING NEUTRAL ENDOPEPTIDASE; SCLEROSTIN; T LYMPHOCYTE ANTIGEN;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL LINE; CONTROLLED STUDY; FRACTURE HEALING; IDG SW3 CELL LINE; IN VITRO STUDY; IN VIVO STUDY; LONG BONE; MORPHOLOGY; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCYTE; PHENOTYPE; PROTEIN EXPRESSION;

ANIMALS; ANTIGENS, POLYOMAVIRUS TRANSFORMING; BIOLOGICAL MARKERS; BONE AND BONES; CALCIFICATION, PHYSIOLOGIC; CALCIUM; CELL DIFFERENTIATION; CELL LINE; CELL MOVEMENT; CELL PROLIFERATION; EXTRACELLULAR SPACE; FIBRILLAR COLLAGENS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GREEN FLUORESCENT PROTEINS; MICE; MICROSPHERES; OSTEOCYTES; OSTEOGENESIS; RATS; TIME FACTORS; TRANSCRIPTION FACTORS; WOUND HEALING;

EID: 80054979878     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.465     Document Type: Article

References (37)

1. Barragan-Adjemian C, Nicolella D, Dusevich V, Dallas MR, Eick JD, Bonewald LF,. Mechanism by which MLO-A5 late osteoblasts/early osteocytes mineralize in culture: similarities with mineralization of lamellar bone. Calcif Tissue Int. 2006; 79 (5): 340-53. (Pubitemid 44900157)
2. Bonewald LF,. The amazing osteocyte. J Bone Miner Res. 2011; 26 (2): 229-38.
3. 2 in osteocytes blocks glucocorticoid-induced apoptosis through both the β-catenin and PKA pathways. J Bone Miner Res. 2010; 25 (12): 2657-68.
4. Robling AG, Bellido T, Turner CH,. Mechanical stimulation in vivo reduces osteocyte expression of sclerostin. J Musculoskelet Neuronal Interact. 2006; 6 (4): 354. (Pubitemid 46099713)
5. Gluhak-Heinrich J, Ye L, Bonewald LF, Feng JQ, MacDougall M, Harris SE, Pavlin D,. Mechanical loading stimulates dentin matrix protein 1 (DMP1) expression in osteocytes in vivo. J Bone Miner Res. 2003; 18 (5): 807-17. (Pubitemid 37294963)
6. Poole KE, van Bezooijen RL, Loveridge N, Hamersma H, Papapoulos SE, Lowik CW, Reeve J,. Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation. Faseb J. 2005; 19 (13): 1842-4. (Pubitemid 41598769)
7. Qing H, Divieti Pajevic P, Barry K, Dusevich V, Wysolmerski J, Bonewald L,. PTHR1 in osteocytes plays a major role in perilacunar remodeling through the activation of "osteoclastic" genes in osteocytes. J Bone Min Res. 2010, submitted.
8. Klein-Nulend J, Bonewald L,. Chapter 8: The Osteocyte. In:, Bilezikian J, Raisz L, Martin T, editors. 3rd ed, Principles of Bone Biology. Academic Press, Inc.; 2008. pp. 151-73.
9. van Bezooijen RL, Roelen BA, Visser A, van der Wee-Pals L, de Wilt E, Karperien M, Hamersma H, Papapoulos SE, ten Dijke P, Lowik CW,. Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist. J Exp Med. 2004; 199 (6): 805-14. (Pubitemid 38375200)
10. Kato Y, Windle JJ, Koop BA, Mundy GR, Bonewald LF,. Establishment of an osteocyte-like cell line, MLO-Y4. J Bone Miner Res. 1997; 12 (12): 2014-23. (Pubitemid 27524478)
11. Kato Y, Boskey A, Spevak L, Dallas M, Hori M, Bonewald LF,. Establishment of an osteoid preosteocyte-like cell MLO-A5 that spontaneously mineralizes in culture. J Bone Miner Res. 2001; 16 (9): 1622-33. (Pubitemid 32786431)
12. Kalajzic I, Braut A, Guo D, Jiang X, Kronenberg MS, Mina M, Harris MA, Harris SE, Rowe DW,. Dentin matrix protein 1 expression during osteoblastic differentiation, generation of an osteocyte GFP-transgene. Bone. 2004; 35 (1): 74-82. (Pubitemid 38789150)
13. Juppner H, Wolf M, Salusky IB,. FGF-23: more than a regulator of renal phosphate handling? J Bone Min Res. 2010; 25 (10): 2091-97.
14. Jat PS, Noble MD, Ataliotis P, Tanaka Y, Yannoutsos N, Larsen L, Kioussis D,. Direct derivation of conditionally immortal cell lines from an H-2Kb-tsA58 transgenic mouse. Proc Natl Acad Sci U S A. 1991; 88 (12): 5096-100. (Pubitemid 21914690)
15. Sittichockechaiwut A, Scutt AM, Ryan AJ, Bonewald LF, Reilly GC,. Use of rapidly mineralising osteoblasts and short periods of mechanical loading to accelerate matrix maturation in 3D scaffolds. Bone. 2009; 44 (5): 822-9.
16. Kern G, Flucher BE,. Localization of transgenes and genotyping of H-2kb-tsA58 transgenic mice. Biotechniques. 2005; 38 (1): 38, 40, 42.
17. Boyan BD, Schwdrtz Z, Bonewald LF, Swain LD,. Localization of 1,25(OH),D, responsive alkaline phosphatase in osteoblast-like cells (ROS 17R.8, MG-63 and MC3T3) and growth cartilage cells in culture. J Biol Chcm. 1989; 264: 11879-86. (Pubitemid 19185357)
18. Aalami OO, Nacamuli RP, Lenton KA, Cowan CM, Fang TD, Fong KD, Shi YY, Song HM, Sahar DE, Longaker MT,. Applications of a mouse model of calvarial healing: differences in regenerative abilities of juveniles and adults. Plast Reconstr Surg. 2004; 114 (3): 713-20. (Pubitemid 40090375)
19. Bouxsein ML, Boyd SK, Christiansen BA, Guldberg RE, Jepsen KJ, Müller R,. Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J Bone Miner Res. 2010; 25 (7): 1468-86.
20. Moester MJ, Papapoulos SE, Lowik CW, van Bezooijen RL,. Sclerostin: current knowledge and future perspectives. Calcif Tissue Int. 2010; 87 (2): 99-107.
21. Bellido T,. Downregulation of SOST/sclerostin by PTH: a novel mechanism of hormonal control of bone formation mediated by osteocytes. J Musculoskelet Neuronal Interact. 2006; 6 (4): 358-9. (Pubitemid 46099716)
22. Bellido T, Ali AA, Gubrij I, Plotkin LI, Fu Q, O'Brien CA, Manolagas SC, Jilka RL,. Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: a novel mechanism for hormonal control of osteoblastogenesis. Endocrinology. 2005; 146 (11): 4577-83. (Pubitemid 41446595)
23. O'Brien CA, Plotkin LI, Galli C, Goellner JJ, Gortazar AR, Allen MR, Robling AG, Bouxsein M, Schipani E, Turner CH, Jilka RL, Weinstein RS, Manolagas SC, Bellido T,. Control of bone mass and remodeling by PTH receptor signaling in osteocytes. PLoS One. 2008; 3 (8): e2942.
24. Partridge NC, Alcorn D, Michelangeli VP, Ryan G, Martin TJ,. Morphological and biochemical characterization of four clonal osteogenic sarcoma cell lines of rat origin. Cancer Res. 1983; 43 (9): 4308-14. (Pubitemid 13044057)
25. Rodan SB, Imai Y, Thiede MA, Wesolowski G, Thompson D, Bar-Shavit Z, Shull S, Mann K, Rodan GA,. Characterization of a human osteosarcoma cell line (Saos-2) with osteoblastic properties. Cancer Res. 1987; 47 (18): 4961-6. (Pubitemid 17143047)
26. Fogh J, Trempe G,. New human tumor cell lines. In:, Fogh J, editor. Human Tumor Cell Lines in vitro. New York: Plenum Press; 1975. pp. 155-9.
27. Zhang K, Barragan-Adjemian C, Ye L, Kotha S, Dallas M, Lu Y, Zhao S, Harris M, Harris SE, Feng JQ, Bonewald LF,. E11/gp38 selective expression in osteocytes: regulation by mechanical strain and role in dendrite elongation. Mol Cell Biol. 2006; 26 (12): 4539-52. (Pubitemid 43877574)
28. Genetos DC, Geist DJ, Liu D, Donahue HJ, Duncan RL,. Fluid shear-induced ATP secretion mediates prostaglandin release in MC3T3-E1 osteoblasts. J Bone Miner Res. 2005; 20 (1): 41-9. (Pubitemid 41716217)
29. Li X, Ominsky MS, Niu QT, Sun N, Daugherty B, D'Agostin D, Kurahara C, Gao Y, Cao J, Gong J, Asuncion F, Barrero M, Warmington K, Dwyer D, Stolina M, Morony S, Sarosi I, Kostenuik PJ, Lacey DL, Simonet WS, Ke HZ, Paszty C,. Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength. J Bone Miner Res. 2008; 23 (6): 860-9. (Pubitemid 351768804)
30. Li X, Ominsky MS, Warmington KS, Morony S, Gong J, Cao J, Gao Y, Shalhoub V, Tipton B, Haldankar R, Chen Q, Winters A, Boone T, Geng Z, Niu QT, Ke HZ, Kostenuik PJ, Simonet WS, Lacey DL, Paszty C,. Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis. J Bone Miner Res. 2009; 24 (4): 578-88.
31. Vincent C, Findlay DM, Welldon KJ, Wijenayaka AR, Zheng TS, Haynes DR, Fazzalari NL, Avdokiou A, Atkins GJ,. Proinflammatory cytokines TNF-related Weak Inducer of Apoptosis (TWEAK) and TNFα induce the mitogen activated protein kinase (MAPK)-dependent expression of sclerostin in human osteoblasts. J Bone Min Res. 2009; 24 (8): 1434-49.
32. Keller H, Kneissel M,. SOST is a target gene for PTH in bone. Bone. 2005; 37 (2): 148-58. (Pubitemid 40962421)
33. Feng JQ, Ward LM, Liu S, Lu Y, Xie Y, Yuan B, Yu X, Rauch F, Davis SI, Zhang S, Rios H, Drezner MK, Quarles LD, Bonewald LF, White KE,. Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism. Nat Genet. 2006; 38 (11): 1310-5. (Pubitemid 44646294)
34. Pereira RC, Juppner H, Azucena-Serrano CE, Yadin O, Salusky IB, Wesseling-Perry K,. Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic kidney disease. Bone. 2009; 45 (6): 1161-8.
35. Marsell R, Jonsson KB,. The phosphate regulating hormone fibroblast growth factor-23. Acta Physiol (Oxf). 2010; 200 (2): 97-106.
36. Allen KJ, Reyes R, Demmler K, Mercer JF, Williamson R, Whitehead RH,. Conditionally immortalized mouse hepatocytes for use in liver gene therapy. J Gastroenterol Hepatol. 2000; 15 (11): 1325-32.
37. Whitehead RH, VanEeden PE, Noble MD, Ataliotis P, Jat PS,. Establishment of conditionally immortalized epithelial cell lines from both colon and small intestine of adult H-2Kb-tsA58 transgenic mice. Proc Natl Acad Sci U S A. 1993; 90 (2): 587-91. (Pubitemid 23028908)